Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Exeligen Scientific

Exeligen Scientific?uq=AFYHfsyn
OOB STATUS
Out of Business LATEST DEAL TYPE
Description

Developer of a genome editing technology. The company offers genomic engineering products and services such as clustered regularly inter-spaced short palindromic repeats, CRISPR and Cas-related systems.

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 5505 Lakeview Canyon Road
  • Westlake Village, CA 91362
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Exeligen Scientific’s full profile, request a free trial.

Exeligen Scientific Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Nov-2016 Completed Out of Business
1. Accelerator/Incubator 28-Oct-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Exeligen Scientific Executive Team (3)

Name Title Board
Seat
Contact
Info
David Aguilar Ph.D Co-Founder & Chief Executive Officer
Ferrukh Sheikh Co-Founder, Chief Financial Officer & President
Mark Stevens Ph.D Co-Founder, President of Research & Development & Chief Scientific Officer